Clinical Trial Update: A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Pfizer's Phase 2 trial evaluated the safety and efficacy of Tofimilast in adults with chronic obstructive pulmonary disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tofimilast

Snippet

Sponsor: Pfizer | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED